Di Pietrantonio, M.; Brescini, L.; Candi, J.; Gianluca, M.; Pallotta, F.; Mazzanti, S.; Mantini, P.; Candelaresi, B.; Olivieri, S.; Ginevri, F.;
et al. Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study. Antibiotics 2022, 11, 321.
https://doi.org/10.3390/antibiotics11030321
AMA Style
Di Pietrantonio M, Brescini L, Candi J, Gianluca M, Pallotta F, Mazzanti S, Mantini P, Candelaresi B, Olivieri S, Ginevri F,
et al. Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study. Antibiotics. 2022; 11(3):321.
https://doi.org/10.3390/antibiotics11030321
Chicago/Turabian Style
Di Pietrantonio, Maria, Lucia Brescini, Jennifer Candi, Morroni Gianluca, Francesco Pallotta, Sara Mazzanti, Paolo Mantini, Bianca Candelaresi, Silvia Olivieri, Francesco Ginevri,
and et al. 2022. "Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study" Antibiotics 11, no. 3: 321.
https://doi.org/10.3390/antibiotics11030321
APA Style
Di Pietrantonio, M., Brescini, L., Candi, J., Gianluca, M., Pallotta, F., Mazzanti, S., Mantini, P., Candelaresi, B., Olivieri, S., Ginevri, F., Cesaretti, G., Castelletti, S., Cocci, E., Polo, R. G., Cerutti, E., Simonetti, O., Cirioni, O., Tavio, M., Giacometti, A.,
& Barchiesi, F.
(2022). Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study. Antibiotics, 11(3), 321.
https://doi.org/10.3390/antibiotics11030321
